DE68912582D1 - Anti-hiv-mittel. - Google Patents

Anti-hiv-mittel.

Info

Publication number
DE68912582D1
DE68912582D1 DE89901753T DE68912582T DE68912582D1 DE 68912582 D1 DE68912582 D1 DE 68912582D1 DE 89901753 T DE89901753 T DE 89901753T DE 68912582 T DE68912582 T DE 68912582T DE 68912582 D1 DE68912582 D1 DE 68912582D1
Authority
DE
Germany
Prior art keywords
hiv
medium
hiv medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89901753T
Other languages
English (en)
Other versions
DE68912582T2 (de
Inventor
Hajime Meiji Institute Tsunoo
Masao Meiji Institute O Takami
Kenji Meiji Institute Mizumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Milk Products Co Ltd filed Critical Meiji Milk Products Co Ltd
Application granted granted Critical
Publication of DE68912582D1 publication Critical patent/DE68912582D1/de
Publication of DE68912582T2 publication Critical patent/DE68912582T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/03Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE68912582T 1989-01-09 1989-01-30 Anti-hiv-mittel. Expired - Lifetime DE68912582T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP257489 1989-01-09
JP1879089 1989-01-27
PCT/JP1989/000094 WO1990007340A1 (en) 1989-01-09 1989-01-30 Anti-hiv agent

Publications (2)

Publication Number Publication Date
DE68912582D1 true DE68912582D1 (de) 1994-03-03
DE68912582T2 DE68912582T2 (de) 1994-08-11

Family

ID=26335984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68912582T Expired - Lifetime DE68912582T2 (de) 1989-01-09 1989-01-30 Anti-hiv-mittel.

Country Status (7)

Country Link
US (1) US5164486A (de)
EP (1) EP0406416B1 (de)
KR (1) KR0128098B1 (de)
AU (1) AU636104B2 (de)
DE (1) DE68912582T2 (de)
OA (1) OA09308A (de)
WO (1) WO1990007340A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9100434A (nl) * 1991-03-11 1992-10-01 Rijksuniversiteit Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
US5869457A (en) * 1991-03-11 1999-02-09 Rijksuniversiteit Te Groningen Modified proteins and their use for controlling viral infections
US5336782A (en) * 1991-04-24 1994-08-09 Kuraray Co., Ltd. Long chain carboxylic acid imide ester
EP0601183A4 (de) * 1991-08-02 1996-12-04 Meiji Milk Prod Co Ltd Anti-hiv medikament.
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
US5952009A (en) * 1996-03-20 1999-09-14 New York Blood Center Methods for preventing the transmission of or treating patients infected with herpesvirus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE316928B (de) * 1966-11-25 1969-11-03 Kabi Ab
JPS56147724A (en) * 1980-04-18 1981-11-16 Teijin Ltd Igm derivative and immunoglobulin preparation for intravenous injection containing said compound as effective component
EP0158487B1 (de) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stabile Interleukin-2-Zusammensetzung
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
JPH01500829A (ja) * 1986-09-04 1989-03-23 シタス コーポレイション 医薬組成物のためのスクシニル化されたインターロイキン―2
FR2625902A3 (fr) * 1988-12-12 1989-07-21 Zagyansky Yuly Un nouveau moyen de lutte contre les virus (tels les virus du sida) et contre les bacteries avec les anticorps modifies par changement de charge

Also Published As

Publication number Publication date
OA09308A (en) 1992-09-15
DE68912582T2 (de) 1994-08-11
KR910700067A (ko) 1991-03-13
AU2937489A (en) 1990-08-01
WO1990007340A1 (en) 1990-07-12
EP0406416B1 (de) 1994-01-19
AU636104B2 (en) 1993-04-22
KR0128098B1 (ko) 1998-04-04
EP0406416A4 (en) 1991-11-21
EP0406416A1 (de) 1991-01-09
US5164486A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
DE59000343D1 (de) Schaelmesser.
DE69020982T2 (de) Vulkanisierungsform.
DE69017059T2 (de) Mehrplattenspieler.
DE59007379D1 (de) 3-Phenylbenzofuran-2-one.
FI901652A0 (fi) Genomstroemningsmaetanordning foer flytande media enligt ultraljudgaongtidsprincipen.
DE59007974D1 (de) Uretero-Renoskop.
FI903041A0 (fi) Foerdelningsanordning foer medium.
DE69020950T2 (de) Mehrplattenspieler.
DE59004522D1 (de) Mikrodosiergerät.
DE68912582D1 (de) Anti-hiv-mittel.
DE59005135D1 (de) Formstein.
DE59008431D1 (de) Triazolylsulfonamide.
DE69004689D1 (de) N-fluoropyridinium-pyridin-heptafluorodiborat.
DE59009874D1 (de) Iminosilane.
DE59008846D1 (de) Fluorphenylpyrimidine.
DE69013427D1 (de) Glyoxyl-Cyclohexendione.
FI890299A (fi) Form.
DE59007719D1 (de) Pyrazol-3-carbonsäureamide.
DE69008037D1 (de) Satteldecke.
DE69005107D1 (de) Fusskreuz.
FI890300A (fi) Form.
DE69001981D1 (de) Kaefigmutter.
DE59004564D1 (de) Mappe.
DE59005993D1 (de) Dibenzofuranylbiphenyle.
FI895774A (fi) Volymstroemmaetare foer medium.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition